# Phathom Pharmaceuticals, Inc. (PHAT) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Phathom Pharmaceuticals, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/PHAT/mda/fy2025/): filed 2026-02-26; accession 0001193125-26-073379 (https://www.sec.gov/Archives/edgar/data/1783183/000119312526073379/phat-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/PHAT/mda/fy2024/): filed 2025-03-06; accession 0000950170-25-034183 (https://www.sec.gov/Archives/edgar/data/1783183/000095017025034183/phat-20241231.htm)
- [FY 2023 MD&A](/company/PHAT/mda/fy2023/): filed 2024-03-07; accession 0000950170-24-027910 (https://www.sec.gov/Archives/edgar/data/1783183/000095017024027910/phat-20231231.htm)
- [FY 2022 MD&A](/company/PHAT/mda/fy2022/): filed 2023-02-28; accession 0000950170-23-004875 (https://www.sec.gov/Archives/edgar/data/1783183/000095017023004875/phat-20221231.htm)
- [FY 2021 MD&A](/company/PHAT/mda/fy2021/): filed 2022-03-01; accession 0000950170-22-002536 (https://www.sec.gov/Archives/edgar/data/1783183/000095017022002536/phat-20211231.htm)

Back to /company/PHAT/